Please login to the form below
emphysema
This page shows the latest emphysema news and features for those working in and with pharma, biotech and healthcare.
Policy and public health: ML and AI in healthcare
If you smoke ten packs of cigarettes per day, you will likely suffer from emphysema or COPD or some other respiratory illness.
Latest news
-
GSK gets maintenance indication for Trelegy
Specifically, the new approval is for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and/or emphysema, which could make Trelegy a
-
Shire receives FDA nod for self-infusion of Glassia
Shire's emphysema therapy Glassia has received FDA approval for an expanded label, marking the first time that patients can self-infuse at home. ... Glassia, an alpha-1 proteinase inhibitor, is licensed for the treatment of adults with emphysema due to
-
FDA approves Boehringer COPD spray Striverdi Respimat
Licence from US regulator will also allow it to treat chronic bronchitis or emphysema. ... The FDA said it can now be used to treat COPD patients, including those with chronic bronchitis or emphysema to help unblock airways, but the regulator wants the
-
GSK wins US approval for Seretide successor Breo Ellipta
The FDA licensed Breo Ellipta to treat airflow obstruction in patients with COPD, including chronic bronchitis and emphysema, and said it can also be used to reduce exacerbations of COPD.
-
GSK submits COPD drug in US and EU
including chronic bronchitis and emphysema.
More from news
Approximately 1 fully matching, plus 14 partially matching documents found.
Latest Intelligence
-
‘How is your day?’
swelling that obstructs airways) and Alpha-1 Antitrypsin Deficiency (causes chronic emphysema and liver damage).
-
Deal Watch table for January 2015
Collaboration agreement. 480. PneumRx/BTG. Includes RePneu a coil to open airways in emphysema patients.
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
- HCP ENGAGEMENT STUDY: Pharma shifts top priority to HCP insights and impact metrics
- AstraZeneca/Merck’s Lynparza combination recommended by NICE for advanced ovarian cancer
- BMS shares positive phase 3 results for Opdivo/Yervoy combination in colorectal cancer
- Stanford Medicine researchers find blood tests help predict organ failure
- GSK and GCOA report reveals global inequities in adult immunisation uptake
- A “Leaky Pipeline” and the Loss of Talented Female Physicians
No results were found
PMHub
Evoke Kyne
Evoke Kyne is an award-winning communications agency that harnesses insight, experience and creativity to advance health and wellbeing around the world. We were founded on the belief that...
Latest intelligence
- Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
- ...
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
